FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018258661> ?p ?o ?g. }

• W2018258661 endingPage "8574" @default.
• W2018258661 startingPage "8564" @default.
• W2018258661 abstract "A seven valent pneumococcal conjugate vaccine (PCV7) was introduced in the Norwegian childhood immunization programme in 2006, and since then the incidence of invasive pneumococcal disease has declined substantially. Recently, two new second generation pneumococcal conjugate vaccines have become available, and an update of the economic evidence is needed. The aim of this study was to estimate incremental costs, health effects and cost-effectiveness of the pneumococcal conjugate vaccines PCV7, PCV13 and PHiD-CV in Norway. We used a Markov model to estimate costs and epidemiological burden of pneumococcal- and NTHi-related diseases (invasive pneumococcal disease (IPD), Community Acquired Pneumonia (CAP) and acute otitis media (AOM)) for a specific birth cohort. Using the most relevant evidence and assumptions for a Norwegian setting, we calculated incremental costs, health effects and cost-effectiveness for different vaccination strategies. In addition we performed sensitivity analyses for key parameters, tested key assumptions in scenario analyses and explored overall model uncertainty using probabilistic sensitivity analysis. The model predicts that both PCV13 and PHiD-CV provide more health gains at a lower cost than PCV7. Differences in health gains between the two second generation vaccines are small for invasive pneumococcal disease but larger for acute otitis media and myringotomy procedures. Consequently, PHiD-CV saves more disease treatment costs and indirect costs than PCV13. This study predicts that, compared to PVC13, PHiD-CV entails lower costs and greater benefits if the latter is measured in terms of quality adjusted life years. PVC13 entails more life years gained than PHiD-CV, but those come at a cost of NOK 3.1 million (∼€0.4 million) per life year. The results indicate that PHiD-CV is cost-effective compared to PCV13 in the Norwegian setting." @default.
• W2018258661 created "2016-06-24" @default.
• W2018258661 creator A5009314809 @default.
• W2018258661 creator A5021378802 @default.
• W2018258661 creator A5034710814 @default.
• W2018258661 creator A5051240379 @default.
• W2018258661 creator A5060634299 @default.
• W2018258661 date "2011-11-01" @default.
• W2018258661 modified "2023-09-27" @default.
• W2018258661 title "Economic evaluation of second generation pneumococcal conjugate vaccines in Norway" @default.
• W2018258661 cites W1590587045 @default.
• W2018258661 cites W182083651 @default.
• W2018258661 cites W1975514483 @default.
• W2018258661 cites W1980070970 @default.
• W2018258661 cites W1983130542 @default.
• W2018258661 cites W1983436663 @default.
• W2018258661 cites W1987920526 @default.
• W2018258661 cites W1988495044 @default.
• W2018258661 cites W2008764347 @default.
• W2018258661 cites W2013803462 @default.
• W2018258661 cites W2018407773 @default.
• W2018258661 cites W2023690749 @default.
• W2018258661 cites W2027818737 @default.
• W2018258661 cites W2030187973 @default.
• W2018258661 cites W2035758731 @default.
• W2018258661 cites W2036814749 @default.
• W2018258661 cites W2049386698 @default.
• W2018258661 cites W2058572722 @default.
• W2018258661 cites W2059608310 @default.
• W2018258661 cites W2082235861 @default.
• W2018258661 cites W2090865013 @default.
• W2018258661 cites W2094204413 @default.
• W2018258661 cites W2095354990 @default.
• W2018258661 cites W2097362862 @default.
• W2018258661 cites W2116355732 @default.
• W2018258661 cites W2120944044 @default.
• W2018258661 cites W2144063972 @default.
• W2018258661 cites W2150085320 @default.
• W2018258661 cites W2150106013 @default.
• W2018258661 cites W2168061864 @default.
• W2018258661 cites W3025897641 @default.
• W2018258661 cites W4294316044 @default.
• W2018258661 cites W45730193 @default.
• W2018258661 cites W48044459 @default.
• W2018258661 doi "https://doi.org/10.1016/j.vaccine.2011.09.025" @default.
• W2018258661 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21945264" @default.
• W2018258661 hasPublicationYear "2011" @default.
• W2018258661 type Work @default.
• W2018258661 sameAs 2018258661 @default.
• W2018258661 citedByCount "34" @default.
• W2018258661 countsByYear W20182586612012 @default.
• W2018258661 countsByYear W20182586612013 @default.
• W2018258661 countsByYear W20182586612014 @default.
• W2018258661 countsByYear W20182586612015 @default.
• W2018258661 countsByYear W20182586612016 @default.
• W2018258661 countsByYear W20182586612017 @default.
• W2018258661 countsByYear W20182586612019 @default.
• W2018258661 countsByYear W20182586612020 @default.
• W2018258661 countsByYear W20182586612021 @default.
• W2018258661 countsByYear W20182586612022 @default.
• W2018258661 countsByYear W20182586612023 @default.
• W2018258661 crossrefType "journal-article" @default.
• W2018258661 hasAuthorship W2018258661A5009314809 @default.
• W2018258661 hasAuthorship W2018258661A5021378802 @default.
• W2018258661 hasAuthorship W2018258661A5034710814 @default.
• W2018258661 hasAuthorship W2018258661A5051240379 @default.
• W2018258661 hasAuthorship W2018258661A5060634299 @default.
• W2018258661 hasConcept C112930515 @default.
• W2018258661 hasConcept C147483822 @default.
• W2018258661 hasConcept C177713679 @default.
• W2018258661 hasConcept C187212893 @default.
• W2018258661 hasConcept C203014093 @default.
• W2018258661 hasConcept C22070199 @default.
• W2018258661 hasConcept C2778866548 @default.
• W2018258661 hasConcept C2779583294 @default.
• W2018258661 hasConcept C2780664029 @default.
• W2018258661 hasConcept C2780801004 @default.
• W2018258661 hasConcept C2781253189 @default.
• W2018258661 hasConcept C2908647359 @default.
• W2018258661 hasConcept C3019080777 @default.
• W2018258661 hasConcept C523546767 @default.
• W2018258661 hasConcept C54355233 @default.
• W2018258661 hasConcept C64332521 @default.
• W2018258661 hasConcept C71924100 @default.
• W2018258661 hasConcept C86803240 @default.
• W2018258661 hasConcept C99454951 @default.
• W2018258661 hasConceptScore W2018258661C112930515 @default.
• W2018258661 hasConceptScore W2018258661C147483822 @default.
• W2018258661 hasConceptScore W2018258661C177713679 @default.
• W2018258661 hasConceptScore W2018258661C187212893 @default.
• W2018258661 hasConceptScore W2018258661C203014093 @default.
• W2018258661 hasConceptScore W2018258661C22070199 @default.
• W2018258661 hasConceptScore W2018258661C2778866548 @default.
• W2018258661 hasConceptScore W2018258661C2779583294 @default.
• W2018258661 hasConceptScore W2018258661C2780664029 @default.
• W2018258661 hasConceptScore W2018258661C2780801004 @default.
• W2018258661 hasConceptScore W2018258661C2781253189 @default.
• W2018258661 hasConceptScore W2018258661C2908647359 @default.

• next